116 related articles for article (PubMed ID: 23315429)
1. Propionyl-L-Carnitine versus Pentoxifylline : Improvement in Walking Capacity in Patients with Intermittent Claudication.
Strano A
Clin Drug Investig; 2002 Nov; 22(Suppl 1):1-6. PubMed ID: 23315429
[TBL] [Abstract][Full Text] [Related]
2. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study.
Brevetti G; Perna S; Sabbá C; Martone VD; Condorelli M
J Am Coll Cardiol; 1995 Nov; 26(6):1411-6. PubMed ID: 7594063
[TBL] [Abstract][Full Text] [Related]
3. A study on the efficacy and safety assessment of propionyl-L-carnitine tablets in treatment of intermittent claudication.
Luo T; Li J; Li L; Yang B; Liu C; Zheng Q; Jin B; Chen Z; Li K; Zhang X; Zhang J
Thromb Res; 2013 Oct; 132(4):427-32. PubMed ID: 23998557
[TBL] [Abstract][Full Text] [Related]
4. European multicenter study on propionyl-L-carnitine in intermittent claudication.
Brevetti G; Diehm C; Lambert D
J Am Coll Cardiol; 1999 Nov; 34(5):1618-24. PubMed ID: 10551714
[TBL] [Abstract][Full Text] [Related]
5. Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication.
Hiatt WR; Regensteiner JG; Creager MA; Hirsch AT; Cooke JP; Olin JW; Gorbunov GN; Isner J; Lukjanov YV; Tsitsiashvili MS; Zabelskaya TF; Amato A
Am J Med; 2001 Jun; 110(8):616-22. PubMed ID: 11382369
[TBL] [Abstract][Full Text] [Related]
6. A systematic review to evaluate the effectiveness of carnitine supplementation in improving walking performance among individuals with intermittent claudication.
Delaney CL; Spark JI; Thomas J; Wong YT; Chan LT; Miller MD
Atherosclerosis; 2013 Jul; 229(1):1-9. PubMed ID: 23557982
[TBL] [Abstract][Full Text] [Related]
7. Effect of propionyl-L-carnitine on quality of life in intermittent claudication.
Brevetti G; Perna S; Sabba C; Martone VD; Di Iorio A; Barletta G
Am J Cardiol; 1997 Mar; 79(6):777-80. PubMed ID: 9070558
[TBL] [Abstract][Full Text] [Related]
8. [Randomized study of tolerability, safety and efficacy of Pletax in intermittent claudication].
Kazantsev AN; Goriunov SV; Ershova OB; Erofeeva SB; Gurgenian EV
Angiol Sosud Khir; 2021; 27(1):7-16. PubMed ID: 33825723
[TBL] [Abstract][Full Text] [Related]
9. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial.
Kakkos SK; Geroulakos G; Nicolaides AN
Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):164-75. PubMed ID: 15890545
[TBL] [Abstract][Full Text] [Related]
10. Carnitine and peripheral arterial disease.
Hiatt WR
Ann N Y Acad Sci; 2004 Nov; 1033():92-8. PubMed ID: 15591006
[TBL] [Abstract][Full Text] [Related]
11. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
Hood SC; Moher D; Barber GG
CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
Guest JF; Davie AM; Clegg JP
Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
[TBL] [Abstract][Full Text] [Related]
13. New treatment options in intermittent claudication: the US experience.
Hiatt WR
Int J Clin Pract Suppl; 2001 Apr; (119):20-7. PubMed ID: 11355276
[TBL] [Abstract][Full Text] [Related]
14. Rapid foot and calf compression increases walking distance in patients with intermittent claudication: results of a randomized study.
Ramaswami G; D'Ayala M; Hollier LH; Deutsch R; McElhinney AJ
J Vasc Surg; 2005 May; 41(5):794-801. PubMed ID: 15886663
[TBL] [Abstract][Full Text] [Related]
15. Propionyl-L-carnitine.
Wiseman LR; Brogden RN
Drugs Aging; 1998 Mar; 12(3):243-8; discussion 249-50. PubMed ID: 9534023
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis of propionyl-L-carnitine effects on exercise performance in patients with claudication.
Brass EP; Koster D; Hiatt WR; Amato A
Vasc Med; 2013 Feb; 18(1):3-12. PubMed ID: 23321261
[TBL] [Abstract][Full Text] [Related]
17. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up.
Delis KT; Nicolaides AN; Wolfe JH; Stansby G
J Vasc Surg; 2000 Apr; 31(4):650-61. PubMed ID: 10753272
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of pentoxifylline, buflomedil, and nifedipine in the treatment of intermittent claudication of the lower limbs.
Chacón-Quevedo A; Eguaras MG; Calleja F; Garcia MA; Roman M; Casares J; Muñoz I; Concha M
Angiology; 1994 Jul; 45(7):647-53. PubMed ID: 8024164
[TBL] [Abstract][Full Text] [Related]
19. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation.
De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Incandela L; Bucci M; Geroulakos G; Ramaswami G; Vasdekis S; Agus G; Bavera P; Ippolito E
Angiology; 2002; 53 Suppl 1():S7-12. PubMed ID: 11865838
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriche stage II.
Riccioni C; Sarcinella R; Palermo G; Izzo A; Liguori M; Koverech A; Messano M; Virmani A
Int Angiol; 2008 Jun; 27(3):253-9. PubMed ID: 18506129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
